Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment

Inclusion criteria

• Patients over 18 years of age
• Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
• Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation)

Inclusion criteria

for the control arm (treated by ACEi):

• Patients over 18 years of age
• Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
• Patients, who tolerate ACEi treatment

Exclusion criteria

• Cholestasis, severe hepatic insufficiency
• Allergy to telmisartan
• Gravidity or lactation

Exclusion criteria

for the arm of patient treated by ACEi:

• Cholestasis, severe hepatic insufficiency
• Allergy to ACEi
• Gravidity or lactation